Board of Directors
Shlomo Ben-Haim, MD, D.Sc – Co-Founder and Chairman
Dr. Ben-Haim is the co-founder of a number of successful medical and biomedical companies in the fields of congestive heart failure, obesity, diabetes, esthetics and cosmetics, anti-viral medications, deep vein thrombosis prevention, therapy for limb ischemia and post-stroke and sports-injury rehabilitation. His formal education is in the fields of nuclear physics, mathematics, biomedical engineering, philosophy and medicine. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics, at Harvard University and the Technion – Israel Institute of Technology. Dr. Ben-Haim has published over 100 scientific papers in peer-reviewed journals and holds over 200 patents and patent applications.
Prof. Harold Lebovitz, MD, FACE– Director
Dr. Lebovitz has previously served as Chief of the Section of Endocrinology and Diabetes, and Director of the National Institutes of Health (NIH)-sponsored Clinical Research Center at the State University of New York Health Science Center, where he currently serves as a Professor. He also currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE). He is an internationally recognized authority in the field of diabetes and is author or co-author of more than 200 peer-reviewed publications and 100 chapters or books. Dr. Lebovitz received his BSc and MD from the University of Pittsburgh.
Irit Yaniv, MD, MBA – Director
Irit is an experienced and accomplished Senior Executive in the life sciences industry, both in the medical devices and bio-pharma fields. Her 15 years of progressively increasing responsibilities in this field have included successfully managing product development (from inception through launch), designing and implementing clinical studies and pivotal trials, achieving FDA regulatory approvals both in the forms of PMA and 510K, effectively launching the sales of new products as well as increasing the sales of existing lines. Previous companies include: Bayer, Sunlight Medical, BSP and Brainsgate. Irit Holds an MD degree from Ben-Gurion University and an MBA from the Recanati Graduate School of Business Administration at the Tel Aviv University.
Dr. Simos Kedikoglou, MD, CFA, MBA – Director
Dr. Simos Kedikoglou is the President of the MedInvest group. He was previously a Corporate Vice President of Business Development for Boston Scientific with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. Prior to Boston Scientific, Simos was an Associate Partner with McKinsey & Company in the US, focusing on M&A and has advised clients in completed healthcare deals with a combined value of $45 billion. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction and a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.
Antony Owers, FCA – Managing Director
Mr. Owers was previously with the accounting firm KPMG from in London, São Paulo, Brazil and Curaçao, in the latter as a Senior Partner for many years. He has been a Fellow of the Institute of Chartered Accountants in England and Wales since 1980, and has served as the British Consul to the Dutch Caribbean islands since 1997. He is also treasurer of many charitable foundations in the Netherlands Antilles including the Red Cross, International School, National Trust, Consular Corps, Rotary and Uniting for Children.